Why Is Therapeutic Misconception So Prevalent?

Therapeutic misconception (TM)—when clinical research participants fail to adequately grasp the difference between participating in a clinical trial and receiving ordinary clinical care—has long been recognized as a significant problem in consent to clinical trials. We suggest that TM does not prima...

Descrizione completa

Salvato in:  
Dettagli Bibliografici
Autori: Lidz, Charles W. (Autore) ; Albert, Karen (Autore) ; Appelbaum, Paul (Autore) ; Dunn, Laura B. (Autore) ; Overton, Eve (Autore) ; Pivovarova, Ekaterina (Autore)
Tipo di documento: Elettronico Articolo
Lingua:Inglese
Verificare la disponibilità: HBZ Gateway
Journals Online & Print:
Caricamento...
Fernleihe:Fernleihe für die Fachinformationsdienste
Pubblicazione: Cambridge Univ. Press 2015
In: Cambridge quarterly of healthcare ethics
Anno: 2015, Volume: 24, Fascicolo: 2, Pagine: 231-241
Altre parole chiave:B therapeutic misconception
B Informed Consent
B research ethics
B Clinical Trials
Accesso online: Volltext (lizenzpflichtig)
Volltext (lizenzpflichtig)
Descrizione
Riepilogo:Therapeutic misconception (TM)—when clinical research participants fail to adequately grasp the difference between participating in a clinical trial and receiving ordinary clinical care—has long been recognized as a significant problem in consent to clinical trials. We suggest that TM does not primarily reflect inadequate disclosure or participants’ incompetence. Instead, TM arises from divergent primary cognitive frames. The researchers’ frame places the clinical trial in the context of scientific designs for assessing intervention efficacy. In contrast, most participants have a cognitive frame that is personal and focused primarily on their medical problems. To illustrate this, we draw on interview material from both clinical researchers and participants in clinical trials. We suggest that reducing TM requires encouraging subjects to adjust their frame, not just add information to their existing frame. What is necessary is a scientific reframing of participation in a clinical trial.
ISSN:1469-2147
Comprende:Enthalten in: Cambridge quarterly of healthcare ethics
Persistent identifiers:DOI: 10.1017/S096318011400053X